Arax Advisory Partners’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97K Buy
1,141
+1,027
+901% +$82.6K ﹤0.01% 2752
2026
Q1
$8.6K Buy
114
+22
+24% +$1.62K ﹤0.01% 2524
2025
Q4
$6.25K Sell
92
-1,868
-95% -$117K ﹤0.01% 2727
2025
Q3
$112K Buy
1,960
+1,873
+2,153% +$111K ﹤0.01% 1496
2025
Q2
$4.82K Buy
87
+33
+61% +$1.55K ﹤0.01% 2263
2025
Q1
$2.36K Buy
+54
New +$2.35K ﹤0.01% 2020

Other funds holding DBD

Arax Advisory Partners's DBD Position: Q2 2026 in Review

Arax Advisory Partners increased its Diebold Nixdorf (DBD) stake by 901% in Q2 2026, buying an estimated $82.6K and bringing the position to 1,141 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

Arax Advisory Partners first reported a position in DBD in Q1 2025 and has held it in 6 quarters since. The position peaked at $112K in Q3 2025. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Arax Advisory Partners held 1,141 shares of Diebold Nixdorf worth $97K as of Q2 2026.
  • Arax Advisory Partners bought 1,027 Diebold Nixdorf shares in Q2 2026, an estimated $82.6K.
  • Diebold Nixdorf made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2752 holding.
  • Arax Advisory Partners first reported a position in Diebold Nixdorf in Q1 2025 and has held it in 6 quarters since.
  • Arax Advisory Partners's Diebold Nixdorf position peaked at $112K in Q3 2025.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.